Alidad Mireskandari
Amministratore Delegato presso DiamiR LLC
Profilo
Dr. Alidad Mireskandari is a Chief Executive Officer at DiamiR LLC and a Chief Executive Officer & Director at DiamiR Biosciences Corp.
He is on the Board of Directors at DiamiR Biosciences Corp.
Dr. Mireskandari was previously employed as a Chief Development Officer by Interpace Biosciences, Inc., a President & Chief Executive Officer by JS Genetics, Inc., and a Manager-Hedge Fund by Paribas North America, Inc.
Posizioni attive di Alidad Mireskandari
| Società | Posizione | Inizio |
|---|---|---|
DiamiR LLC
 DiamiR LLC BiotechnologyHealth Technology Part of DiamiR Biosciences Corp., DiamiR LLC engages in the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma. The company is based in Monmouth Junction, NJ. The company was founded by Kira S. Sheinerman. Alidad Mireskandari has been the CEO of the company since 2022. | Amministratore Delegato | 11/07/2022 |
DiamiR Biosciences Corp.
 DiamiR Biosciences Corp. Medical/Nursing ServicesHealth Services DiamiR Biosciences Corp. operates as a molecular diagnostics company. It focuses on development and commercialization of innovative blood-based tests for detection and monitoring of Mild Cognitive Impairment (MCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), and other neurodegenerative diseases (NDs). The company was founded on June 16, 2014 and is headquartered in Monmouth, NJ. | Amministratore Delegato | 01/07/2022 |
Precedenti posizioni note di Alidad Mireskandari
| Società | Posizione | Fine |
|---|---|---|
BNP Paribas USA, Inc.
 BNP Paribas USA, Inc. Financial ConglomeratesFinance BNP Paribas USA, Inc. provides banking and financial services. It offers corporate and investment banking services; asset management services to institutional and retail clients; commercial banking services, including business credit, deposit, and cash management for mid-market and larger companies, and small businesses; and retail banking services. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2009 |
JS Genetics, Inc.
 JS Genetics, Inc. Medical/Nursing ServicesHealth Services JS Genetics, Inc. provides DNA diagnostic tests services. The company is headquartered in Short Hills, NJ. | Amministratore Delegato | - |
| INTERPACE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INTERPACE BIOSCIENCES, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
JS Genetics, Inc.
JS Genetics, Inc. Medical/Nursing ServicesHealth Services JS Genetics, Inc. provides DNA diagnostic tests services. The company is headquartered in Short Hills, NJ. | Health Services |
BNP Paribas USA, Inc.
BNP Paribas USA, Inc. Financial ConglomeratesFinance BNP Paribas USA, Inc. provides banking and financial services. It offers corporate and investment banking services; asset management services to institutional and retail clients; commercial banking services, including business credit, deposit, and cash management for mid-market and larger companies, and small businesses; and retail banking services. The company is headquartered in New York, NY. | Finance |
DiamiR Biosciences Corp.
DiamiR Biosciences Corp. Medical/Nursing ServicesHealth Services DiamiR Biosciences Corp. operates as a molecular diagnostics company. It focuses on development and commercialization of innovative blood-based tests for detection and monitoring of Mild Cognitive Impairment (MCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), and other neurodegenerative diseases (NDs). The company was founded on June 16, 2014 and is headquartered in Monmouth, NJ. | Health Services |
DiamiR LLC
DiamiR LLC BiotechnologyHealth Technology Part of DiamiR Biosciences Corp., DiamiR LLC engages in the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma. The company is based in Monmouth Junction, NJ. The company was founded by Kira S. Sheinerman. Alidad Mireskandari has been the CEO of the company since 2022. | Health Technology |
- Borsa valori
- Insiders
- Alidad Mireskandari
